Abstract: A multi-phase latex particle composition includes at least two different heteropolymers defining at least two different phases. The heteropolymers are selected such that a cumulative percentage of i) any heteropolymers including less than 30% of a C6 or greater (meth)acrylate monomer ranges from about 20 wt % to about 80 wt % of a total particle composition weight; ii) any heteropolymers having a glass transition temperature (Tg) ranging from 15° C. to 75° C. ranges from about 20 wt % to about 70 wt % of the total weight; iii) any heteropolymers having a Tg greater than 75° C. is greater than 30 wt % of the total weight; iv) any heteropolymers having a Tg less than 15° C. is less than 20 wt % of the total weight; and v) an aromatic group monomer is less than 10 wt % of the total weight.

Abstract: A lightweight end cap for an ammunition cartridge, said end cap having a central axis along its axial length, with a first radius; wherein said end cap further comprises a swept volume rebate; having a second radius less than the first radius, wherein the second radius is at least 10% smaller than the first radius, and wherein the swept volume rebate extends along at least 10% of the axial length of said end cap, wherein the end cap further comprises an extractor groove suitable for receiving an ejection mechanism.

Abstract: According to the present invention, there is provided an ammunition belt link comprising, a sprung wire, said sprung wire arranged to form a first receiving portion suitable for retaining a first ammunition cartridge, a second receiving portion suitable for retaining a second ammunition cartridge, a spacer between said first receiving and second receiving portions, an ammunition cartridge locator aide, said locator aid locates in an ejector groove of a received cartridge and, the wire ammunition belt link further comprising a support surface suitable for retaining the first and/or second ammunition cartridge.

Abstract: The present application relates to treatment of myeloproliferative neoplasms using the JAK1/JAK2 inhibitor, ruxolitinib, in combination with a BET protein inhibitor, 2,2,4-trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-1,4-benzoxazin-3(4H)-one, wherein the combination is unexpectedly synergistic.

Abstract: The invention relates to a method of improved ammunition production, particularly to a metal matrix composite(MMC) end cap, suitable for forming a cartridge case, said end cap comprising an admixture of a metal powder, a binder matrix material, wherein said admixture has been caused to solidify in the shape of said end cap.

Abstract: The invention relates to a method of improved ammunition production, more specifically to a cellular structure end cap, suitable for an ammunition round, said end cap comprising a porous 3D spatial structure in the shape of said end cap, wherein in said porous 3D spatial structure comprises a surface skin.

Abstract: A lightweight end cap for an ammunition cartridge, said end cap having a central axis along its axial length, with a first radius; wherein said end cap further comprises a swept volume rebate; having a second radius less than the first radius, wherein the second radius is at least 10% smaller than the first radius, and wherein the swept volume rebate extends along at least 10% of the axial length of said end cap, wherein the end cap further comprises an extractor groove suitable for receiving an ejection mechanism.

Abstract: There is provided an ammunition belt link comprising, a sprung wire, said sprung wire arranged to form a first receiving portion suitable for retaining a first ammunition cartridge, a second receiving portion suitable for retaining a second ammunition cartridge, a spacer between said first receiving and second receiving portions; and an ammunition cartridge locator aide, said aide locates in an ejector groove of a received cartridge.

Abstract: The present application relates to treatment of myeloproliferative neoplasms using the JAK1/JAK2 inhibitor, ruxolitinib, in combination with a BET protein inhibitor, 2,2,4-trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-1,4-benzoxazin-3(4H)-one, wherein the combination is unexpectedly synergistic.

Abstract: There is provided an ammunition belt link comprising, a sprung wire, said sprung wire arranged to form a first receiving portion suitable for retaining a first ammunition cartridge, a second receiving portion suitable for retaining a second ammunition cartridge, a spacer between said first receiving and second receiving portions; and an ammunition cartridge locator aide, said aide locates in an ejector groove of a received cartridge.

Abstract: According to the present invention, there is provided an ammunition belt link comprising, a sprung wire, said sprung wire arranged to form a first receiving portion suitable for retaining a first ammunition cartridge, a second receiving portion suitable for retaining a second ammunition cartridge, a spacer between said first receiving and second receiving portions, an ammunition cartridge locator aide, said locator aid locates in an ejector groove of a received cartridge and, the wire ammunition belt link further comprising a support surface suitable for retaining the first and/or second ammunition cartridge.

Abstract: A textile printing material set includes a fabric substrate and an aqueous ink composition. The aqueous ink composition includes an aqueous ink vehicle, pigment, and from 2 wt % to 15 wt % of acrylic core-shell latex particles having an acrylic core copolymer with a glass transition temperature from ?50° C. to 30° C. and an acrylic shell copolymer having a glass transition temperature from 50° C. to 130° C. The acrylic core copolymer and the acrylic shell copolymer of the acrylic core-shell latex particles in this example are present at an average weight ratio from 1:1 to 9:1.

Abstract: The present application relates to treatment of myeloproliferative neoplasms using the JAK1/JAK2 inhibitor, ruxolitinib, in combination with a BET protein inhibitor, 2,2,4-trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-1,4-benzoxazin-3(4H)-one, wherein the combination is unexpectedly synergistic.

Abstract: There is disclosed a tracer munition. There is provided a tracer munition for selective activation, the tracer munition comprising: an electronic tracer device, said tracer munition comprising at least one cavity capable of receiving said electronic tracer device wherein the electronic tracer device comprises an electrical power source and an electronic emitter, whereupon selective activation of the electronic tracer device, said electronic emitter emits radiation.

Abstract: There is disclosed a tracer munition. There is provided a tracer munition for selective activation, the tracer munition comprising: an electronic tracer device, said tracer munition comprising at least one cavity capable of receiving said electronic tracer device wherein the electronic tracer device comprises an electrical power source and an electronic emitter, whereupon selective activation of the electronic tracer device, said electronic emitter emits radiation.

Abstract: A cartridge casing comprising a casing tube formed substantially of metal with a closed end and an open end. The casing tube bounds at least part of a head cap entered into the open end of the tube. The head cap is fixed relative to the tube. An end wall defines the closed end opposite the head cap end of the cartridge. The end wall comprises a weakened region.

Abstract: A cartridge casing comprises a casing tube having a first end and a head cap. The first end of the casing tube abuts and is joined with the head cap such that an orifice in the first end of the casing tube is aligned with a passage in the head cap to define a flash passage. The head cap and casing tube are held together by a deformable member.

Abstract: A cartridge casing comprises a casing tube and a head cap. The casing tube bounds at least part of the head cap. The head cap is being fixed relative to the tube by a welding process.

Abstract: A cartridge casing comprising a casing tube formed substantially of metal with a closed end and an open end. The casing tube bounds at least part of a head cap entered into the open end of the tube. The head cap is fixed relative to the tube. An end wall defines the closed end opposite the head cap end of the cartridge. The end wall comprises a weakened region.

Abstract: The invention relates to a conductive connection assembly (5), a method for manufacturing the same and a kit for a body (23) comprising carbon fibre-reinforced material, e.g. for a vehicle comprising a carbon fibre-reinforced body (23), with an electrical structural network for conducting electric discharges. The conductive connection assembly (5) includes a conductive interconnection element (1) with a conductive braid material (B). Furthermore, a kit is provided, the kit including at least two conductive connection assemblies (5) that are provided with differently shaped interconnection elements (1). Finally, a method that comprises the step of reshaping longitudinal ends (3, 4) of a braid material (B) is provided according to the invention.